Back to Search Start Over

Conserved γδ T cell selection by BTNL proteins limits progression of human inflammatory bowel disease.

Authors :
Dart RJ
Zlatareva I
Vantourout P
Theodoridis E
Amar A
Kannambath S
East P
Recaldin T
Mansfield JC
Lamb CA
Parkes M
Irving PM
Prescott NJ
Hayday AC
Source :
Science (New York, N.Y.) [Science] 2023 Sep 15; Vol. 381 (6663), pp. eadh0301. Date of Electronic Publication: 2023 Sep 15.
Publication Year :
2023

Abstract

Murine intraepithelial γδ T cells include distinct tissue-protective cells selected by epithelial butyrophilin-like (BTNL) heteromers. To determine whether this biology is conserved in humans, we characterized the colonic γδ T cell compartment, identifying a diverse repertoire that includes a phenotypically distinct subset coexpressing T cell receptor Vγ4 and the epithelium-binding integrin CD103. This subset was disproportionately diminished and dysregulated in inflammatory bowel disease, whereas on-treatment CD103 <superscript>+</superscript> γδ T cell restoration was associated with sustained inflammatory bowel disease remission. Moreover, CD103 <superscript>+</superscript> Vγ4 <superscript>+</superscript> cell dysregulation and loss were also displayed by humans with germline BTNL3/BTNL8 hypomorphism, which we identified as a risk factor for penetrating Crohn's disease (CD). Thus, BTNL-dependent selection and/or maintenance of distinct tissue-intrinsic γδ T cells appears to be an evolutionarily conserved axis limiting the progression of a complex, multifactorial, tissue-damaging disease of increasing global incidence.

Details

Language :
English
ISSN :
1095-9203
Volume :
381
Issue :
6663
Database :
MEDLINE
Journal :
Science (New York, N.Y.)
Publication Type :
Academic Journal
Accession number :
37708268
Full Text :
https://doi.org/10.1126/science.adh0301